Navigation Links
Phyhealth Appoints Gerald H. Priceman as Medical Director
Date:5/1/2008

e such a highly regarded medical professional on board in this important role. We look forward to his contribution."

About Physicians Healthcare Management Group, Inc.

Physicians Healthcare Management Group, Inc. (Phyhealth) is a developer of community-based health maintenance organizations (HMOs) that are owned and operated in partnership with the participating physicians. Phyhealth Plans are designed to deliver high-quality affordable healthcare by enabling physicians to assume end-to-end management of healthcare for their patients. The Phyhealth model empowers physicians to provide preventive healthcare and proactively manage their patients' general health by aligning incentives amongst the HMO, physician and the patient. Phyhealth intends to offer additional value-added products and services in cooperation with physicians, including medical malpractice insurance, local care facilities and wellness programs, as well as information technologies such as secure electronic medical records.

Forward-Looking Statements

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Physicians Healthcare Management Group, Inc, and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Additio
'/>"/>

SOURCE Physicians Healthcare Management Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Phyhealth Concludes $1.5 Million Financing for Launch of Its Pilot Community-Based HMO
2. Phyhealth Submits HMO Applications with Required Federal and State Agencies
3. Phyhealth HMO Applications Accepted by All Required Federal and State Agencies
4. Phyhealth Files Historical Financials With the Pink Sheets and Takes Next Step Toward Becoming Fully Reporting
5. Phyhealth Signs Agreement with Advantica EyeCare to Provide Vision Services for Pilot HMO
6. WorldHeart Appoints David Pellone Chief Financial Officer
7. Novo Nordisk Appoints New Leader of North American Business
8. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
9. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
10. Resonant Medical Appoints New Vice President of Global Sales
11. Response Biomedical appoints S. Wayne Kay Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... Narconon International,s manageme...bilitation and education centers throughout the co... of students and other community members during Re...ip,s (NFP) Red Ribbon Week is considered the natio... is held during the end of October each year, whic...
(Date:11/5/2009)... Lumenis® Ltd. a global developer, manufacture...uency devices for ophthalmic, surgical and aesthet... a clinical study into the efficacy of Selective R...). The study will take place at the Tel Aviv Medic... Anat Loewenstein MD. , (...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Volcano Corporation (Nasd...ure and sales of products for the diagnosis and tr... today reported revenues of $53.9 million for the ...r the quarter ended September 30, 2009, represent ...illion in the third quarter of 2008. Revenues for ...
(Date:11/5/2009)...ds unique mix of bacteria for each person , ..."atlas" of bacterial life on and within the human ...and forearms are a veritable United Nations of ger...sequencing technologies, pinpointed specific bacte...thin the body. They found a wide variability of ba...
(Date:11/5/2009)...ts, higher costs than in other countries , ...ed States lags behind other developed countries in...new international survey of primary care doctors. ...tries in the survey, yet a majority of U.S. primar...rd care, and a wide majority of primary care physi...
Breaking Medicine News(10 mins):Health News:Narconon Centers Educate Thousands During Red Ribbon Week 2Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 2Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 3Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 4Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 5Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 6Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 2Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 3Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 4Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 5Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 6Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 7Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 8Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 9Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 10Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 11Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 12Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 13Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 14Health News:Germs Mingle Most on Palms, Feet, Forearms 2Health News:Germs Mingle Most on Palms, Feet, Forearms 3Health News:Doctors Point Out Gaps in U.S. Health Care 2
...ve cholesterol treatment might be an option for pe...cardiovascular disease say // researchers based on...ve major clinical trials involving cholesterol-low...grams per deciliter.The updated guidelines suggest...
...kids on vitamins too early may result in asthma or...tation during the first six months after birth has...ren // and food allergies in children who are only...ated with being male, having a smoker in the house...
...hows mixing warfarin with ginseng, one of the best...t consequences. Researches say // anyone who takes..., should tell his or her doctor. They also urge do...dex, which means precise dosing is crucial and wit...
...ows soy protein with isoflavones does not have a b...al density, or cholesterol in postmenopausal women...en levels after menopause is related to a decrease...f menopause, yet recent studies have shown many ri...
...ed by smokers in public may be more damaging for y...according to a new study that shows // there may b... smoke or second-hand smoke in public than previou...rst study to examine the risks of additional expos...
... years, hospital infections have increased nearly ...nfections every year, which is more than // those ...in cancer, combined. Each year, about 2 million...s used to treat them, leaving few effective therap...
Other Medicine News:
(Date:11/5/2009)...swire/ -- Renee Cobos, MD, a board certified derma... the University of California, Irvine, announced t... results with Thermage CPT®. The updated syst...ouring, features a new vibrating hand piece that i...omfort. ,, "Thermage has always been popular w...
(Date:11/5/2009)...wire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX )...y reported revenues of $50.8 million for the third...nefit from changes in accounting estimates resulti...to prior period revenue. Third quarter revenue in...comparable period in 2008, which included a $2.5 m...
(Date:11/5/2009)...wswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ...d on the unmet needs in women,s health and oncolog...nancial results for the three months ended Septemb...arter, in October 2009, Bionovo successfully compl... million shares of common stock together with appr...
Breaking Medicine Technology:Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 2Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 3Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 4Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 5Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 7Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 8Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 9Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 10Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 11Bionovo Announces Third Quarter 2009 Highlights and Financial Results 2Bionovo Announces Third Quarter 2009 Highlights and Financial Results 3Bionovo Announces Third Quarter 2009 Highlights and Financial Results 4Bionovo Announces Third Quarter 2009 Highlights and Financial Results 5Bionovo Announces Third Quarter 2009 Highlights and Financial Results 6Bionovo Announces Third Quarter 2009 Highlights and Financial Results 7Bionovo Announces Third Quarter 2009 Highlights and Financial Results 8Bionovo Announces Third Quarter 2009 Highlights and Financial Results 9Famous Names Get Single Neurons Fired Up 52757 1Famous Names Get Single Neurons Fired Up 52757 2NovaBay 28R 29 Pharmaceuticals to Present at Jesup 26 Lamont 2009 Growth Stock Conference 13204 1NovaBay 28R 29 Pharmaceuticals to Present at Jesup 26 Lamont 2009 Growth Stock Conference 13204 2NovaBay 28R 29 Pharmaceuticals to Present at Jesup 26 Lamont 2009 Growth Stock Conference 13204 3Premier Visiting Nurse Selects Cardiocom Telehealth Technology 52752 1Premier Visiting Nurse Selects Cardiocom Telehealth Technology 52752 2
...oday at 44th Annual Meeting of EASL , , Managemen...ng Q1 Financial Results Call at 5 P.M. EDT Today ...Inc. (Nasdaq: ANDS ) today announced that ANA598...ymerase inhibitor, demonstrated potent antiviral a...in a Phase Ib study in which patients chronically ...
...l regimen yielded nearly double SVR rate compared ... HCV protease inhibitor SCH 900518 presented at EA...23 Schering-Plough Corporation (NYSE: SGP ) tod... study showed boceprevir, its investigational oral...th peginterferon alfa-2b and ribavirin, significan...
Other Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12
Grooved Segmental Buckle and Oval Sponge Kits
Silicone Pad (80 Style)
Silicone Sleeve (270 Style)
Meridional Implant (106 Style)
Medicine Products: